BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 27189378)

  • 1. Hyper IgM Syndrome: a Report from the USIDNET Registry.
    Leven EA; Maffucci P; Ochs HD; Scholl PR; Buckley RH; Fuleihan RL; Geha RS; Cunningham CK; Bonilla FA; Conley ME; Ferdman RM; Hernandez-Trujillo V; Puck JM; Sullivan K; Secord EA; Ramesh M; Cunningham-Rundles C
    J Clin Immunol; 2016 Jul; 36(5):490-501. PubMed ID: 27189378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pitfalls of "hyper"-IgM syndrome: a new CD40 ligand mutation in the presence of low IgM levels. A case report and a critical review of the literature.
    Heinold A; Hanebeck B; Daniel V; Heyder J; Tran TH; Döhler B; Greil J; Müller FM
    Infection; 2010 Dec; 38(6):491-6. PubMed ID: 20981468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First report of the Hyper-IgM syndrome Registry of the Latin American Society for Immunodeficiencies: novel mutations, unique infections, and outcomes.
    Cabral-Marques O; Klaver S; Schimke LF; Ascendino ÉH; Khan TA; Pereira PV; Falcai A; Vargas-Hernández A; Santos-Argumedo L; Bezrodnik L; Moreira I; Seminario G; Di Giovanni D; Raccio AG; Porras O; Weber CW; Ferreira JF; Tavares FS; de Carvalho E; Valente CF; Kuntze G; Galicchio M; King A; Rosário-Filho NA; Grota MB; dos Santos Vilela MM; Di Gesu RS; Lima S; de Souza Moura L; Talesnik E; Mansour E; Roxo-Junior P; Aldave JC; Goudouris E; Pinto-Mariz F; Berrón-Ruiz L; Staines-Boone T; Calderón WO; del Carmen Zarate-Hernández M; Grumach AS; Sorensen R; Durandy A; Torgerson TR; Carvalho BT; Espinosa-Rosales F; Ochs HD; Condino-Neto A
    J Clin Immunol; 2014 Feb; 34(2):146-56. PubMed ID: 24402618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Analysis of Patients with Two Different Types of Hyper IgM Syndrome.
    Alizadeh Z; Mazinani M; Houshmand M; Shakerian L; Nourizadeh M; Pourpak Z; Fazlollahi MR
    Immunol Invest; 2018 Oct; 47(7):745-753. PubMed ID: 30081731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Unrelated umbilical cord blood stem cell transplantation in the treatment of hyper-IgM syndrome caused by CD40 ligand gene mutation: a report of three cases and literature review].
    Wang P; Qian XW; Wang HS; Jiang WJ; Sun JQ; Wang XC; Zhai XW
    Zhonghua Er Ke Za Zhi; 2021 Oct; 59(10):830-835. PubMed ID: 34587678
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical features and genetic analysis of Taiwanese patients with the hyper IgM syndrome phenotype.
    Lee WI; Huang JL; Yeh KW; Yang MJ; Lai MC; Chen LC; Ou LS; Yao TC; Lin SJ; Jaing TH; Chen SH; Hsieh MY; Yu HH; Chien YH; Shyur SD
    Pediatr Infect Dis J; 2013 Sep; 32(9):1010-6. PubMed ID: 23538518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful haploidentical PBSCT with subsequent T-cell addbacks in a boy with HyperIgM syndrome presenting as severe congenital neutropenia.
    Jasinska A; Kalwak K; Trelinska J; Borowiec M; Piatosa B; Zeman K; Mlynarski W
    Pediatr Transplant; 2013 Feb; 17(1):E37-40. PubMed ID: 22928961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospects for modulating the CD40/CD40L pathway in the therapy of the hyper-IgM syndrome.
    Meng X; Yang B; Suen WC
    Innate Immun; 2018 Jan; 24(1):4-10. PubMed ID: 29132233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation.
    de la Morena MT; Leonard D; Torgerson TR; Cabral-Marques O; Slatter M; Aghamohammadi A; Chandra S; Murguia-Favela L; Bonilla FA; Kanariou M; Damrongwatanasuk R; Kuo CY; Dvorak CC; Meyts I; Chen K; Kobrynski L; Kapoor N; Richter D; DiGiovanni D; Dhalla F; Farmaki E; Speckmann C; Español T; Shcherbina A; Hanson IC; Litzman J; Routes JM; Wong M; Fuleihan R; Seneviratne SL; Small TN; Janda A; Bezrodnik L; Seger R; Raccio AG; Edgar JD; Chou J; Abbott JK; van Montfrans J; González-Granado LI; Bunin N; Kutukculer N; Gray P; Seminario G; Pasic S; Aquino V; Wysocki C; Abolhassani H; Dorsey M; Cunningham-Rundles C; Knutsen AP; Sleasman J; Costa Carvalho BT; Condino-Neto A; Grunebaum E; Chapel H; Ochs HD; Filipovich A; Cowan M; Gennery A; Cant A; Notarangelo LD; Roifman CM
    J Allergy Clin Immunol; 2017 Apr; 139(4):1282-1292. PubMed ID: 27697500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory Complications in Patients with Hyper IgM Syndrome.
    Moazzami B; Yazdani R; Azizi G; Kiaei F; Tafakori M; Modaresi M; Shirzadi R; Mahdaviani SA; Sohani M; Abolhassani H; Aghamohammadi A
    J Clin Immunol; 2019 Aug; 39(6):557-568. PubMed ID: 31183658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients.
    Winkelstein JA; Marino MC; Ochs H; Fuleihan R; Scholl PR; Geha R; Stiehm ER; Conley ME
    Medicine (Baltimore); 2003 Nov; 82(6):373-84. PubMed ID: 14663287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and laboratory findings in hyper-IgM syndrome with novel CD40L and AICDA mutations.
    Aghamohammadi A; Parvaneh N; Rezaei N; Moazzami K; Kashef S; Abolhassani H; Imanzadeh A; Mohammadi J; Hammarström L
    J Clin Immunol; 2009 Nov; 29(6):769-76. PubMed ID: 19575287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel and recurrent AID mutations underlie prevalent autosomal recessive form of HIGM in consanguineous patients.
    Ouadani H; Ben-Mustapha I; Ben-ali M; Ben-khemis L; Larguèche B; Boussoffara R; Maalej S; Fetni I; Hassayoun S; Mahfoudh A; Mellouli F; Yalaoui S; Masmoudi H; Bejaoui M; Barbouche MR
    Immunogenetics; 2016 Jan; 68(1):19-28. PubMed ID: 26545377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe congenital neutropenia or hyper-IgM syndrome? A novel mutation of CD40 ligand in a patient with severe neutropenia.
    Rezaei N; Aghamohammadi A; Ramyar A; Pan-Hammarstrom Q; Hammarstrom L
    Int Arch Allergy Immunol; 2008; 147(3):255-9. PubMed ID: 18594157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single-center study points to diverse features and outcome in patients with Hyperimmunoglobulin M Syndrome and Class- Switch Recombination defects.
    Akarsu A; Halaçlı S; Tan Ç; Kuşkonmaz B; Küpesiz A; Çetinkaya D; Sanal Ö; Tezcan İ; Çağdaş D
    Scand J Immunol; 2022 Nov; 96(5):e13213. PubMed ID: 36808635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, immunological, and molecular characterization of hyper-IgM syndrome due to CD40 deficiency in eleven patients.
    Al-Saud BK; Al-Sum Z; Alassiri H; Al-Ghonaium A; Al-Muhsen S; Al-Dhekri H; Arnaout R; Alsmadi O; Borrero E; Abu-Staiteh A; Rawas F; Al-Mousa H; Hawwari A
    J Clin Immunol; 2013 Nov; 33(8):1325-35. PubMed ID: 24122029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and hematopoietic stem cell transplantations for CD40 ligand deficiency in Japan.
    Mitsui-Sekinaka K; Imai K; Sato H; Tomizawa D; Kajiwara M; Nagasawa M; Morio T; Nonoyama S
    J Allergy Clin Immunol; 2015 Oct; 136(4):1018-24. PubMed ID: 25840720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory infections in X-linked hyper-IgM syndrome with CD40LG mutation: a case series of seven children in China.
    Fan H; Huang L; Yang D; Zhang C; Zeng Q; Yin G; Lu G; Shen K
    BMC Pediatr; 2022 Nov; 22(1):675. PubMed ID: 36419145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Common Monogenic Defects in a Large Predominantly Antibody Deficiency Cohort.
    Yazdani R; Abolhassani H; Kiaee F; Habibi S; Azizi G; Tavakol M; Chavoshzadeh Z; Mahdaviani SA; Momen T; Gharagozlou M; Movahedi M; Hamidieh AA; Behniafard N; Nabavi M; Bemanian MH; Arshi S; Molatefi R; Sherkat R; Shirkani A; Amin R; Aleyasin S; Faridhosseini R; Jabbari-Azad F; Mohammadzadeh I; Ghaffari J; Shafiei A; Kalantari A; Mansouri M; Mesdaghi M; Babaie D; Ahanchian H; Khoshkhui M; Soheili H; Eslamian MH; Cheraghi T; Dabbaghzadeh A; Tavassoli M; Kalmarzi RN; Mortazavi SH; Kashef S; Esmaeilzadeh H; Tafaroji J; Khalili A; Zandieh F; Sadeghi-Shabestari M; Darougar S; Behmanesh F; Akbari H; Zandkarimi M; Abolnezhadian F; Fayezi A; Moghtaderi M; Ahmadiafshar A; Shakerian B; Sajedi V; Taghvaei B; Safari M; Heidarzadeh M; Ghalebaghi B; Fathi SM; Darabi B; Bazregari S; Bazargan N; Fallahpour M; Khayatzadeh A; Javahertrash N; Bashardoust B; Zamani M; Mohsenzadeh A; Ebrahimi S; Sharafian S; Vosughimotlagh A; Tafakoridelbari M; Rahim M; Ashournia P; Razaghian A; Rezaei A; Samavat A; Mamishi S; Khazaei HA; Mohammadi J; Negahdari B; Parvaneh N; Rezaei N; Lougaris V; Giliani S; Plebani A; Ochs HD; Hammarström L; Aghamohammadi A
    J Allergy Clin Immunol Pract; 2019 Mar; 7(3):864-878.e9. PubMed ID: 30240888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-linked hyper-IgM syndrome with CD40LG mutation: two case reports and literature review in Taiwanese patients.
    Tsai HY; Yu HH; Chien YH; Chu KH; Lau YL; Lee JH; Wang LC; Chiang BL; Yang YH
    J Microbiol Immunol Infect; 2015 Feb; 48(1):113-8. PubMed ID: 23010537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.